000			02196 a2200625 4500
005			20250515040100.0
264		0	_c20070309
008			200703s 0 0 eng d
022			_a0028-3908
024	7		_a10.1016/j.neuropharm.2006.07.018 _2doi
040			_aNLM _beng _cNLM
100	1		_aNagel, Jens
245	0	0	_aEffects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration. _h[electronic resource]
260			_bNeuropharmacology _cDec 2006
300			_a1163-71 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnalgesics, Non-Narcotic _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aBiotransformation _xdrug effects
650	0	4	_aBlood-Brain Barrier
650	0	4	_aBrain Chemistry _xdrug effects
650	0	4	_aChronic Disease
650	0	4	_aDipeptides _xanalysis
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aExtracellular Fluid _xchemistry
650	0	4	_aGlutamate Carboxypeptidase II _xantagonists & inhibitors
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aLigation
650	0	4	_aMale
650	0	4	_aMicrodialysis
650	0	4	_aModels, Animal
650	0	4	_aNeuralgia _xdrug therapy
650	0	4	_aNeuroprotective Agents _xadministration & dosage
650	0	4	_aOrganophosphorus Compounds _xadministration & dosage
650	0	4	_aPain Threshold _xdrug effects
650	0	4	_aPyridazines _xpharmacology
650	0	4	_aQuinolines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Metabotropic Glutamate _xantagonists & inhibitors
650	0	4	_aSciatic Nerve _xinjuries
700	1		_aBelozertseva, Irina
700	1		_aGreco, Sergio
700	1		_aKashkin, Vladimir
700	1		_aMalyshkin, Andrey
700	1		_aJirgensons, Aigars
700	1		_aShekunova, Elena
700	1		_aEilbacher, Bernd
700	1		_aBespalov, Anton
700	1		_aDanysz, Wojciech
773	0		_tNeuropharmacology _gvol. 51 _gno. 7-8 _gp. 1163-71
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2006.07.018 _zAvailable from publisher's website
999			_c16512240 _d16512240